Licking latency with licorice
AUTOR(ES)
Cohen, Jeffrey I.
FONTE
American Society for Clinical Investigation
RESUMO
Numerous viruses cause latent infections in humans, and reactivation often results in pain and suffering. While vaccines for several of these viruses are available or currently being studied in clinical trials, and antiviral therapies have been successful in preventing or treating active infection, therapy to eradicate latent infection has lagged behind. A new study reported in this issue of the JCI shows that treatment of cells latently infected with Kaposi sarcoma–associated herpesvirus (KSHV) with glycyrrhizic acid, a component of licorice, reduces synthesis of a viral latency protein and induces apoptosis of infected cells. This finding suggests a novel way to interrupt latency.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1052015Documentos Relacionados
- Licorice: A possible anti-inflammatory and anti-ulcer drug
- Long-term ovariectomy changes formalin-induced licking in female rats: the role of estrogens
- Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.
- Epstein-Barr virus with heterogeneous DNA disrupts latency.
- Rapid quantitative analysis of six flavonoids in licorice by ultra-performance convergence chromatography